A breakthrough study highlights Xenon gas as a potential game-changer in treating Alzheimer’s disease, demonstrating its ...

JP Morgan Cazenove and Morgan Stanley were global coordinators on the sale of a 7.7% stake in the UK consumer healthcare ...

As the year gets underway, analysts and biotech executives highlight cell therapy’s pivot from oncology to autoimmune ...

GSK PLC GSK shares rallied 2.63% to £13.28 Wednesday, on what proved to be an all-around great trading session for the stock market, with the FTSE 100 Index UKX rising 1.21% to 8,301.13. Supported by ...

GSK plans five new product approvals by 2025, highlights strong specialty growth, and acquires IDRx for $1 billion to expand its oncology portfolio.

Pfizer Inc. (NYSE:PFE) has announced the sale of shares worth £2.50 billion ($3.05 billion) in British consumer healthcare ...

Embracing a pluralistic vision of corporate governance will help us ensure capitalism's legitimacy and sustainability.

Moderna is down 80% from its 52-week high as revenues continue to fall and the new RSV vaccine has performed poorly. Read my ...

J&J, GSK, Eli Lilly and others struck high-value transactions in the early days of biopharma’s annual kickoff conference.

Pfizer divests $3.05 billion of Haleon shares, cutting its stake to 7.3% in a strategic shift to refocus on core ...

Look deep into nature and then you will understand everything better.” The quote from Albert Einstein is generally deployed ...

Pfizer will sell shares worth 2.50 billion pounds ($3.05 billion) in Haleon, lowering its stake in the British consumer ...